joimax® Announces Major Spike in Attendance at its ESPINEA® Workshops, Reports Record Revenues
KARLSRUHE, Germany--(BUSINESS WIRE)--German-based joimax®, the market leader in technologies and training methods for full-endoscopic and…
4 years ago
Wire Stories
Telecommunications Network Operators, 4Q21 Market Review – 10% Jump Propels Capex to Hit Record $326Billion in 2021 – ResearchAndMarkets.com
DUBLIN--(BUSINESS WIRE)--The "Telecommunications Network Operators: 4Q21 Market Review" report has been added to ResearchAndMarkets.com's offering.…
4 years ago
Asia-Pacific Activated Carbon Markets, 2021-2022 & 2028: Inexpensive Alternatives to Commercial Activated Carbon & Increasing Regulations on Mercury Emissions – ResearchAndMarkets.com
DUBLIN--(BUSINESS WIRE)--The "Asia-Pacific Activated Carbon Market Forecast to 2028 - COVID-19 Impact and Regional Analysis…
4 years ago
India Cards and Payments Markets, Opportunities and Risks Report 2022-2025 – ResearchAndMarkets.com
DUBLIN--(BUSINESS WIRE)--The "India Cards and Payments - Opportunities and Risks to 2025" report has been…
4 years ago
Foresight VCT Plc – Final Results 31 December 2021
FORESIGHT VCT PLCLEI: 213800GNTY699WHACF46 Final results31 December 2021 Foresight VCT plc, managed by Foresight Group…
4 years ago
Foresight VCT Plc – Final Results 31 December 2021
FORESIGHT VCT PLCLEI: 213800GNTY699WHACF46 Final results31 December 2021 Foresight VCT plc, managed by Foresight Group…
4 years ago
Hong Kong Cards and Payments Market Analysis, Opportunities and Risks, 2017-2021 & 2022-2025 – ResearchAndMarkets.com
DUBLIN--(BUSINESS WIRE)--The "Hong Kong Cards and Payments - Opportunities and Risks to 2025" report has…
4 years ago
Ohio Coatings Company, an Esmark and TCC Steel JV, Appoints David Luptak New CEO
SEWICKLEY, Pa.--(BUSINESS WIRE)--Ohio Coatings Company – a joint venture between Esmark, Inc. and TCC Steel…
4 years ago
Global Pulmonary Tuberculosis Clinical Trials Research Report 2022 – ResearchAndMarkets.com
DUBLIN--(BUSINESS WIRE)--The "Pulmonary Tuberculosis - Global Clinical Trials Review, 2022" clinical trials has been added…
4 years ago
European Commission Approves PADCEV™ (enfortumab vedotin) for Locally Advanced or Metastatic Urothelial Cancer
- Enfortumab vedotin is the first medicine approved in the EU for patients who received…
4 years ago